LY-2979165

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLY-2979165
Drug Alias NameLY-2979165MP-101-Lilly
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 2 agonistsMetabotropic glutamate receptor 3 agonists
TargetsMetabotropic glutamate receptor 2Metabotropic glutamate receptor 3
Therapy Area/IndicationsAgitationPsychotic DisordersBipolar Disorder +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And CompanyMediti Pharma Inc
Active IndicationsN/A
Inactive IndicationsAgitationPsychotic DisordersBipolar Disorder +[5] 

Other Information

ATC CodeN/A
Related LinksN/A